USA Researchers Awarded Grants

The U.S. Department of Defense recently awarded researchers at the University of South Alabama (USA) College of Medicine two grants totaling more than $1.07 million to study the replication of mitochondrial DNA (mtDNA). Dr. Mikhail Alexeyev, professor of physiology and cell biology at the college, is principal investigator of the studies. Natalya Kozhukhar, a research technologist, and Viktoriya Pastukh, a research assistant, are working with Alexeyev on the projects. The mitochondria’s main function is to produce energy for the cell. Mitochondrial diseases are a group of inherited genetic disorders that can cause a wide range of health concerns. To treat mitochondrial diseases, scientists first must understand how mtDNA makes copies of itself. Alexeyev’s lab has succeeded in generating human/mouse hybrid cells that maintained human mtDNA for more than a year. Although the approaches are different, the aim of both funded studies is similar: to find out why mouse non-hybrid cells do not replicate human mtDNA.

Read More

Our Roots Run Deep 5k To Be Held January 9

Our Roots Run Deep 5k To Be Held January 9

More Improvements Planned For Foley’s Max Griffin Park

More Improvements Planned For Foley’s Max Griffin Park

USSU First In U.S. To Receive Ethos Universitas Recognition

USSU First In U.S. To Receive Ethos Universitas Recognition

Updated Plans For River Walk Plaza Released

Updated Plans For River Walk Plaza Released

Hive Fest Coming To Hatcher Farms

Hive Fest Coming To Hatcher Farms

Wine On The River To Benefit Aubreigh’s Army

Wine On The River To Benefit Aubreigh’s Army

Port Authority Has Strongest Revenue Year

Port Authority Has Strongest Revenue Year

MBA To Hold Remembrance Ceremony On November 6

MBA To Hold Remembrance Ceremony On November 6

MBA Member Warren Named Cumberland Volunteer Of The Year

MBA Member Warren Named Cumberland Volunteer Of The Year

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.